Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 450-454

  Zhao, Zhujiang ^a   Li, Can ^a   Song, Yunwei ^a   Wu, Qunying ^a,b   Qiao, Fengchang ^a   Fan, Hong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; DNA methyltransferase 3A; Polymerase chain reaction restriction fragment length polymorphism; Single nucleotide polymorphism 448A>G

Indexed keywords

DNA METHYLTRANSFERASE 3A; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855253060     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.488     Document Type: Article

References (16)

1. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J and Kim DH: Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15: 6185-6191, 2009.
2. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298, 1999.
3. Schmidt WM, Sedivy R, Forstner B, Steger GG, Zochbauer-Muller S and Mader RM: Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 46: 766-772, 2007.
4. Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M and Heath JK: Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. Gastroenterology 137: 902-913, 2009.
5. Fan H, Liu D, Qiu X, Qiao F, Wu Q, Su X, Zhang F, Song Y, Zhao Z and Xie W: A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma. BMC Med 8: 12, 2010.
6. Fan H, Liu DS, Zhang SH, Hu JB, Zhang F and Zhao ZJ: DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese. World J Gastroenterol 14: 2230-2234, 2008.
7. Yi JM, Tsai HC, Glockner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G and Eberhart CG: Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 68: 8094-8103, 2008.
8. Jass JR: Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2: 398-405, 2005.
9. Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M and Tanimoto K: Single nucleotide polymorphism in the hypoxia-inducible factor-1α gene in colorectal carcinoma. Oncol Rep 12: 1033-1037, 2004.
10. Mort R, Mo L, McEwan C and Melton DW: Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89: 333-337, 2003.
11. Shin Y, Kim IJ, Kang HC, Park JH, Park HW, Jang SG, Lee MR, Jeong SY, Chang HJ and Ku JL: A functional polymorphism (-347 G->GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 25: 2173-2176, 2004.
12. Shan K, Xiao-Wei M, Na W, Xiu-Feng Z, Deng-Gui W, Wei G, Zheng-Mao Z and Yan L: Association of three single nucleotide polymorphisms of the E-cadherin gene with endometriosis in a Chinese population. Reproduction 134: 373-378, 2007.
13. Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schonfeld P, Roessner A and Gali-Muhtasib H: 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther 312: 525-536, 2005.
14. Nelson RL, Dollear T, Freels S and Persky V: The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 80: 193-197, 1997.
15. Troisi RJ, Freedman AN and Devesa SS: Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 85: 1670-1676, 1999.
16. Anderson WF, Umar A and Brawley OW: Colorectal carcinoma in black and white race. Cancer Metastasis Rev 22: 67-82, 2003.